Towada Products · New Delhi, India · Last updated:
Axitinib is an oral VEGF receptor tyrosine kinase inhibitor used for advanced kidney cancer. Towada Products exports it from New Delhi, India, supplying Inlybest in the 5mg strength to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. Pricing is on enquiry.
Axitinib is an oral tyrosine kinase inhibitor that selectively and potently blocks VEGF receptors 1, 2 and 3. These receptors drive angiogenesis, the growth of new blood vessels that tumours need.
It is approved for advanced renal cell carcinoma: as first-line treatment in combination with pembrolizumab or with avelumab, and on its own after failure of one prior systemic therapy, such as sunitinib or a cytokine. The originator brand is Inlyta.
Blood pressure, thyroid function and urine protein are among the checks made during treatment, and the dose is adjusted by the oncologist. Sunitinib, pazopanib, cabozantinib and lenvatinib, other kinase inhibitors used in kidney cancer, are also in our catalog, so a buyer can compare options in one quotation. The film-coated tablets are kept at room temperature and ship without a cold chain. State the strength and pack size when you enquire. Kidney cancer centres and oncology distributors are the usual buyers, and axitinib is often ordered for patients who also receive an immunotherapy infusion in hospital.
Axitinib is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor. This page describes the medicine for trade buyers; it is not medical advice.
Every axitinib product page on this site. "Listed for" is the use given in our catalog. Availability is confirmed when you enquire.
| Product | Composition | Listed for |
|---|---|---|
| Inlybest 5mg | Axitinib (5mg) | Treatment of Kidney cancer |
Export markets we serve: Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. See our export markets →
Tell us which documents your regulator or customs broker needs and we will confirm what applies to the product you are ordering.
Axitinib is an oral VEGF receptor tyrosine kinase inhibitor used for advanced kidney cancer. It is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor.
Our catalog has 1 axitinib product page in the 5mg strength, from 1 brand: Inlybest. The table on this page links to each product page; availability is confirmed when you enquire.
We ship from New Delhi by international courier or air cargo to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa, and have country pages for the Philippines, Russia, Kazakhstan, Uzbekistan, Iraq, Saudi Arabia and Brazil. Whether axitinib can be imported, and by whom, is decided by the destination country's medicines regulator, so tell us the country and we will confirm what is possible. Every country we cover is listed on our export markets page.
Each shipment travels with a commercial invoice, a packing list and a courier or air waybill. We provide a Certificate of Analysis (CoA) for the batch and, where it is available for the product and the destination country requires it, a Certificate of Pharmaceutical Product (CoPP). A certificate of origin can be arranged on request.
Use the enquiry form on this page, WhatsApp +91 99995 62955 or email H.S.Gandhi@towadaproducts.in. Tell us the brand, strength, quantity and destination country, and we will reply with availability and a formal quotation.
This page is general information for trade buyers. It is not medical advice. Import rules differ by country and change over time; confirm the current requirements with your national medicines regulator before ordering.
Tell us the brand, strength, quantity and destination country. Pricing is confirmed in a formal quote. Prefer WhatsApp? Message +91 99995 62955.
Plain answers to the questions importers ask before ordering medicines from India.
